Title:
SULODEXIDE CONTAINING MEDICINE FOR DIABETIC NEPHROPATHY TREATMENT
Document Type and Number:
Japanese Patent JP2702400
Kind Code:
B2
Abstract:
PURPOSE: To provide the novel medical compsn. for diabetic nephropathy treatment which decreases albumin urine without changing the filtration rate of glomerculus and has low toxicity.
CONSTITUTION: This medicinal compsn. contains the sulodexide (chemical name: glucurono-2-amino-2-deoxyglucansulfate) which is the naturally derived glycosaminoglycan extracted from the intestinal mucosa of mammals having the sulfation degree and anti-coagulation activity lower than those of heparin. This compsn. is preferably formed in the form to allow the medication of the sulodexide at a dose of 41.6 to 124 mg per day. The compd. is conveniently used in all forms medicatable by an oral route, subcutaneous route, muscular route or venous route.
More Like This:
Inventors:
Edgeio Marchi
Gianfranco Tamagnone
Gianfranco Tamagnone
Application Number:
JP9171394A
Publication Date:
January 21, 1998
Filing Date:
April 28, 1994
Export Citation:
Assignee:
Alpha Wasselman Societa Peratini
International Classes:
A61K31/69; A61K31/70; A61K31/715; C08B37/00; A61K31/726; A61K35/38; A61P3/08; A61P3/10; A61P13/02; A61P15/00; A61K; (IPC1-7): A61K31/73; A61K31/73
Attorney, Agent or Firm:
Sota Asahina (2 outside)